Compositions and methods for delivery of il-2 and anti-il-2 for treatment of rheumatoid arthritis
AssigneesArizona Board of Regents on behalf of Arizona State University, Arizona Board of Regents on Behalf of the University of Arizona
InventorsAbhinav Acharya, Hsin-Jung (Joyce) Wu
Life of this patent
Estimating the term…
Abstract
The present invention provides a sustained drug release system comprising IL-2 and anti-IL-2 incorporated into a thermosensitive hydrogel that is engineered to be in liquid form at low temperatures for delivery, but form a hydrogel at physiological body temperatures to act as a sustained release platform. The thermostable hydrogel solution slowly releases IL-2 and anti-IL-2 to provide optimal concentrations for effective treatment of autoimmune diseases.
Claims18
A thermosensitive hydrogel composition comprising:
- a) at least one biologically compatible polymer;
- and
- b) at least one biologically active agent selected from the group consisting of:
- an IL-2 polypeptide component, an anti-IL-2 antibody component and a combination thereof;
- and wherein the composition is liquid at or below room temperature but forms a gel at about 37° C.
Dependencies are inferred from the claim text.